145 related articles for article (PubMed ID: 31958129)
21. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
22. The effect of obesity on recurrence pattern in early breast cancer patients.
Yazici O; Aksoy S; Sendur MA; Babacan T; Ozdemir N; Ozisik Y; Zengin N; Altundag K
J BUON; 2015; 20(4):954-62. PubMed ID: 26416043
[TBL] [Abstract][Full Text] [Related]
23. Association between high body mass index and prognosis of patients with early-stage breast cancer: A systematic review and meta-analysis.
Li Z; Shen G; Shi M; Zheng Y; Guan Y; Xin Y; Wang M; Zhao F; Ren D; Zhao J
Cancer Pathog Ther; 2023 Jul; 1(3):205-215. PubMed ID: 38327841
[TBL] [Abstract][Full Text] [Related]
24. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
Warren LE; Ligibel JA; Chen YH; Truong L; Catalano PJ; Bellon JR
Ann Surg Oncol; 2016 Nov; 23(12):3870-3879. PubMed ID: 27448118
[TBL] [Abstract][Full Text] [Related]
25. Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women.
Hao S; Liu Y; Yu KD; Chen S; Yang WT; Shao ZM
PLoS One; 2015; 10(6):e0129741. PubMed ID: 26107623
[TBL] [Abstract][Full Text] [Related]
26. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
[TBL] [Abstract][Full Text] [Related]
27. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
[TBL] [Abstract][Full Text] [Related]
28. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.
Yu JJ; Shen F; Chen TH; Liang L; Han J; Xing H; Zhou YH; Wang H; Gu WM; Lau WY; Yang T
Br J Surg; 2019 Feb; 106(3):276-285. PubMed ID: 30199100
[TBL] [Abstract][Full Text] [Related]
29. The effect of BMI on long-term outcome in patients with rectal cancer and establishment of a nomogram prediction model.
Zhang Y; Yang X; Zhuang Z; Wei M; Meng W; Deng X; Wang Z
BMC Gastroenterol; 2023 Jan; 23(1):5. PubMed ID: 36624394
[TBL] [Abstract][Full Text] [Related]
30. Body mass index and mortality in patients with gastric cancer: a large cohort study.
Lee JH; Park B; Joo J; Kook MC; Kim YI; Lee JY; Kim CG; Choi IJ; Eom BW; Yoon HM; Ryu KW; Kim YW; Cho SJ
Gastric Cancer; 2018 Nov; 21(6):913-924. PubMed ID: 29651648
[TBL] [Abstract][Full Text] [Related]
31. Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer.
Marret H; Perrotin F; Bougnoux P; Descamps P; Hubert B; Lefranc T; Le Floch O; Lansac J; Body G
Breast Cancer Res Treat; 2001 Mar; 66(1):17-23. PubMed ID: 11368406
[TBL] [Abstract][Full Text] [Related]
32. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM; Geurts SME; van Hellemond IEG; Swinkels ACP; Smorenburg CH; van der Sangen MJC; Kroep JR; de Graaf H; Honkoop AH; Erdkamp FLG; de Roos WK; Linn SC; Imholz ALT; Smidt ML; Vriens IJH; Tjan-Heijnen VCG
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37991939
[TBL] [Abstract][Full Text] [Related]
33. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
Gennari A; Amadori D; Scarpi E; Farolfi A; Paradiso A; Mangia A; Biglia N; Gianni L; Tienghi A; Rocca A; Maltoni R; Antonucci G; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2016 Aug; 159(1):79-86. PubMed ID: 27460638
[TBL] [Abstract][Full Text] [Related]
34. Impact of body mass index on overall survival in patients with metastatic breast cancer.
Saleh K; Carton M; Dieras V; Heudel PE; Brain E; D'Hondt V; Mailliez A; Patsouris A; Mouret-Reynier MA; Goncalves A; Ferrero JM; Petit T; Emile G; Uwer L; Debled M; Dalenc F; Jouannaud C; Ladoire S; Leheurteur M; Cottu P; Veron L; Savignoni A; Courtinard C; Robain M; Delaloge S; Deluche E
Breast; 2021 Feb; 55():16-24. PubMed ID: 33307392
[TBL] [Abstract][Full Text] [Related]
35. Body Mass Index and Outcomes in Breast Cancer Treated With Breast Conservation.
Patel V; James M; Frampton C; Robinson B; Davey V; Timmings L
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):369-376. PubMed ID: 31678226
[TBL] [Abstract][Full Text] [Related]
36. Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
Hyun SH; Ahn HK; Lee JH; Choi JY; Kim BT; Park YH; Im YH; Lee JE; Nam SJ; Lee KH
PLoS One; 2016; 11(10):e0165814. PubMed ID: 27798667
[TBL] [Abstract][Full Text] [Related]
37. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
38. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
39. Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection.
Wang X; Hui TL; Wang MQ; Liu H; Li RY; Song ZC
Oncol Res Treat; 2019; 42(4):195-201. PubMed ID: 30852575
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
Kim JY; Lee DW; Lee KH; Min A; Ryu HS; Lee HB; Moon HG; Kim TY; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA; Kim S
Breast Cancer Res Treat; 2019 Jul; 176(2):453-460. PubMed ID: 31028608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
